Home › NDC Lookup › RxCUI directory › RxCUI 2180330

Darolutamide 300 MG Oral Tablet — RxCUI 2180330

RxNorm drug concept · Semantic clinical drug
RxCUI 2180330 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2180330
Official nameDarolutamide 300 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)8,087 prescriptions · 40 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Darolutamide: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Nubeqa targets a key protein called the androgen receptor, which is what testosterone and similar hormones attach to in order to fuel prostate cancer growth. Regular hormone therap...
  • What exactly is Nubeqa treating — and how is it different from regular hormone therapy?
  • Yes — this one really matters. Taking Nubeqa with food roughly doubles to triples the amount of medicine your body actually absorbs. If you take it on an empty stomach, you're not...
  • Does it matter if I take Nubeqa with food or not?
📖 Read our full Darolutamide guide →

🕸️ Concept Web — How Darolutamide 300 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Darolutamide 300 MG Oral Tablet RxCUI 2180330

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Darolutamide 2180325
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Nubeqa 2180331
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Darolutamide Oral Tablet 2180329
    • Darolutamide Oral Product 2180327
    • Darolutamide Pill 2180328
    • Darolutamide Oral Tablet [Nubeqa] 2180333
    • Nubeqa Oral Product 2180334
    • Nubeqa Pill 2180335
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Darolutamide 300 MG SCDC · 2180326
  • Darolutamide Oral Tablet SCDF · 2180329
  • Darolutamide Oral Product SCDG · 2180327
  • Darolutamide Pill SCDG · 2180328

Brand-Name Concepts

  • Darolutamide 300 MG Oral Tablet [Nubeqa] SBD · 2180336
  • Darolutamide 300 MG [Nubeqa] SBDC · 2180332
  • Darolutamide Oral Tablet [Nubeqa] SBDF · 2180333
  • Nubeqa Oral Product SBDG · 2180334
  • Nubeqa Pill SBDG · 2180335
  • Nubeqa BN · 2180331

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 2180330 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50419-0395-01 1 BOTTLE in 1 CARTON (50419-395-01) / 120 TABLET, FILM COAT... NUBEQA Bayer HealthCare Pharmaceuticals Inc. 2019-07-31
50419-0395-72 1 BOTTLE in 1 CARTON (50419-395-72) / 120 TABLET, FILM COAT... NUBEQA Bayer HealthCare Pharmaceuticals Inc. 2021-03-03
Observed labelers: Bayer HealthCare Pharmaceuticals Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.